Joshua Fitch is an editor for Contemporary Pediatrics.
Early risk factors associated with behavioral dysregulation trajectories
Risk detection practices and targeted interventions promoting adaptive developmental trajectories for at-risk children can be successful by identifying the earliest antecedents of persisting emotional and behavioral dysregulation.
Epinephrine associated with out-of-hospital cardiac arrest survival to discharge
Timing of administration of epinephrine was not associated with survival to discharge for pediatric out-of-hospital cardiac arrest patients, but overall use of epinephrine was.
Getting children's mental health on track
In this Contemporary Pediatrics® interview, Benjamin Maxwell, MD, chief of child and adolescent psychiatry, Rady Children’s Hospital, San Diego, California, details the rise in pediatric mental health concerns, emergency department visits, and the potentially concerning aspects of social media among youth.
How AI can help detect and monitor coughing in infants and young children
Devan Jaganath, MD, MPH, pediatric infectious disease physician, University of California San Francisco Benioff Children's Hospitals, explains how Hyfe AI and other artificial intelligence algorithms can detect and monitor coughing, potentially playing a role in treating RSV patients.
Strategies and tips to tackle dry skin in children
Family history, seasonal change, swimming, and several other factors can contribute to dry skin, according to the Society for Pediatric Dermatology.
Here’s what parents think of pre-owned child health and safety equipment
Over 50% of parents said they have used pre-owned child health and safety equipment. Whether it comes from family or a stranger, from cribs to car seats, all equipment should be inspected and researched before allowing a child to use it according to a C.S. Mott Children’s Hospital National Poll on Children’s Health.
FDA clears algorithm-based automated insulin dosing system for T1D patients 6 years and up
The Beta Bionics iLet ACE Pump and the iLet Dosing Decision software, matched with a compatible FDA-cleared integrated continuous glucose monitor, use an algorithm to determine and command insulin delivery to users.
Government aims to streamline Medicaid billing for students with disabilities, expand health care services in schools
The US Department of Education, US Department of Health and Human Services, and the Biden-Harris Administration look to increase access to school-based health services, including mental health services, amid the national crisis.
Surgeon General issues advisory regarding effects social media has on youths’ mental health
Up to 95% of youth aged 13 to 17 years reported using a social media platform and more than a third said they use social media, “almost constantly,” according to a new advisory from the Surgeon General.
FDA warns G-Supress DX Pediatric Cough Drops could have wrong drug in packaging
Finafta Anesthetic/Analgesic Liquid, containing 60% ethyl alcohol and 5% benzocaine has been found in the G-Supress DX Pediatric Cough Drops packaging, according to the FDA.
FDA approves nalmefene nasal spray for emergency opioid overdose treatment
The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.
FDA approves adalimumab-adbm autoinjector pen for JIA, Crohn’s disease
Patients using adalimumab-adbm for chronic inflammatory disease treatment such as juvenile idiopathic arthritis (JIA), Crohn’s disease, and others, will have an autoinjector option beginning July 1, 2023, according to Boehringer Ingelheim.
How FDA-approved B-VEC will help children with dystrophic epidermolysis bullosa
Following the FDA approval of beremagene geperpavec (B-VEC) (Vyjuvek; Krystal Biotech) to treat dystrophic epidermolysis bullosa (DEB) patients aged 6 months and older, Bernard A. Cohen, MD, discusses its safety and efficacy and how it can change the treatment landscape for DEB.
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older
The FDA has approved Krystal Biotech's beremagene geperpavec (B-VEC) (Vyjuvek; Krystal Biotech) to treat the wounds of dystrophic epidermolysis bullosa (DEB) patients aged 6 months and older. B-VEC is the first FDA-approved gene therapy treatment for DEB, according to the agency. In this Contemporary Pediatrics interview, Raj Chovatiya, MD, PhD, breaks down this much-anticipated FDA approval.
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support
The FDA Advisory Committee recently voted in support of approval for Pfizer's maternal immunization vaccine to help prevent RSV in infants. In this Contemporary Pediatrics® interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital, Chicago, explains what this means for this patient population ahead of an expected FDA decision in August, 2023.
FDA approves expanded label of ibuprofen injection to treat fever and pain in infants
This formulation of ibuprofen is the only non-opioid product approved to treat pain in infants that is delivered through injection, according to Cumberland Pharmaceuticals.
Early screening can play a critical role in pediatric mental health
Thomas R. Young, MD, discusses how important early screening is in children and adolescents with regard to mental health. He believes a reduction in stigma associated with mental health is occurring and that primary care professionals are encouraging youth to discuss what might be bothering them.
Tapinarof cream 1% demonstrates positive topline results for treating pediatric AD
The once-daily topical cream for the treatment of atopic dermatitis (AD) has demonstrated positive topline results in 2 phase 3 studies in adults and children aged 2 years and up. According to Dermavant, a supplemental new drug application (sNDA) filed with the FDA is anticipated in Q1 of 2024.
Glucose levels are in target range at higher percentage with hybrid closed-loop system
A hybrid closed-loop system can deliver glucose levels in the target range at a higher percentage of time among children aged 2 years to younger than 6 years compared to standard-care, according to a study in the New England Journal of Medicine.
Nirsevimab reduces RSV infant hospitalizations by 83% in phase 3b study
Nirsevimab’s efficacy against infant hospitalizations due to respiratory syncytial virus was reinforced after a phase 3b clinical trial, demonstrating an 83% reduction in infant hospitalizations.
What questions do pediatricians need to be prepared for as the federal COVID-19 PHE expires?
Contemporary Pediatrics® Editorial Advisory Board member Andrew Schuman, MD, clinical assistant professor of pediatrics, Geisel School of Medicine, Dartmouth, shares some questions pediatricians can expect from parents as the federal COVID-19 public health emergency (PHE) expires.
AAP: Helping children believed to be self-harming
Since May is Mental Health Awareness Month, the American Academy of Pediatrics is offering several tips to help a suspected self-harming child.
Tina Tan, MD, discusses cost burden associated with the COVID-19 public health emergency expiration
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor-in-chief, Contemporary Pediatrics®, discusses how the cost burden of the federal COVID-19 public health emergency (PHE) expiration on May 11, 2023, can impact testing and vaccination rates among children.
Erica Gunderson, PhD, explains cardiometabolic health, childhood obesity link to breastfeeding
Erica Gunderson, PhD, MS, MPH, RD, senior research scientist, Kaiser Permanente Northern California Division of Research, professor of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine discusses how cardiometabolic health and childhood obesity are linked to breastfeeding. Gunderson also discusses receiving the 2022-2023 March of Dimes Agnes Higgins Award at the Pediatric Academic Societies meeting in Washington, DC on April 30, 2023.
Equitable access to glucose monitoring improves HbA1c levels
Hemoglobin A1c improved in youths with newly diagnosed type 1 diabetes (T1D) when inclusive continuous glucose monitoring (CGM) was initiated, irrespective of ethnicity or insurance status. According to a study published in Jama Network Open, universal CGM could play a role in reducing disparities for minoritized racial and ethnic groups.
Comparing 2019 and 2021 high school students' dietary and physical activity behaviors
A recent CDC Morbidity and Mortality Weekly Report revealed concerning results for US high school students' dietary and physical activity behaviors in 2021 compared to 2019.
WHO: COVID-19 no longer constitutes a public health emergency
COVID-19 is no longer a public health emergency of international concern, the World Health Organization (WHO) announced after its 15th International Health Regulations Emergency Meeting.
Children and adolescents with type 1 diabetes and psychiatric disorders have educational underachievement
According to a recently published study, children and adolescents with type 1 diabetes (T1D) and psychiatric disorders have considerable increased odds for educational underachievement compared to those with T1D alone and healthy students.
Andrew Schuman, MD, discusses sleep systems designed to keep infants in the supine position
Contemporary Pediatrics® Editorial Advisory Board member Andrew Schuman, MD, clinical assistant professor of pediatrics, Geisel School of Medicine, Dartmouth, discusses whether infant sleep systems are needed for a safe sleeping environment.
Rise in autism prevalence highlights continued need for early intervention
Autism prevalence has been an increasing trend even before the COVID-19 pandemic, says J. Thomas Megerian, MD, PhD, FAAP, clinical director, Thompson Autism and Neurodevelopmental Center, Children's Hospital of Orange County. In this Contemporary Pediatrics® interview, watch as he discusses this trend and speaks to the importance of early autism intervention.
2 Clarke Drive Cranbury, NJ 08512